価格表

在庫・価格 : 2025年10月08日 09時00分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human CXCL9/MIG MAb (Clone 49106)
データシート※最新のデータシートでない場合があります
MAB392-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥27,000 1個 追加

在庫・価格 : 2025年10月08日 09時00分 現在

Anti-Human CXCL9/MIG MAb (Clone 49106)

  • 商品コード:MAB392-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥27,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Suyama T et al. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Cancer 2005 Jan;103(2):
Suyama T et al
2005/01/01
Species: Human, Applications: IHC-P PubMed
2 Pinto S et al. Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation. BMC Cancer 2014;14:118
Pinto S et al
2014/01/01
Species: Human, Applications: Flow Cytometry PubMed
3 Oo YH et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J. Immunol. 2010 Mar;184(6):2886-98
Oo YH et al
2010/01/01
Species: Human, Applications: Neutralization PubMed
4 Franciszkiewicz K et al. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention. Cancer Res. 2009 Aug;69(15):6249-55
Franciszkiewicz K et al
2009/01/01
Species: Human, Applications: ICC PubMed
5 Winter D et al. Down-modulation of CXCR3 surface expression and function in CD8+ T cells from cutaneous T cell lymphoma patients. J. Immunol. 2007 Sep;179(6):4272-82
Winter D et al
2007/01/01
Species: Human, Applications: Immunodepletion PubMed
6 Biancotto A et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007 May;109(10):4272-9
Biancotto A et al
2007/01/01
Species: Human, Applications: Luminex Development PubMed
7 Busuttil A et al. CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis. Eur. Respir. J. 2009 Sep;34(3):676-86
Busuttil A et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
8 Grivel JC et al. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 2007 Jun;21(10):1263-72
Grivel JC et al
2007/01/01
Species: Human, Applications: Luminex Development PubMed
9 Zahn S et al. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus. J. Invest. Dermatol. 2011 Jan;131(1):133-40
Zahn S et al
2011/01/01
Species: Human, Applications: IHC-P PubMed
10 Biancotto A et al. Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo. AIDS Res. Hum. Retroviruses 2008 Mar;24(3):453-62
Biancotto A et al
2008/01/01
Species: Human, Applications: Luminex Development PubMed
11 Yoon KC et al. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest. Ophthalmol. Vis. Sci. 2010 Feb;51(2):643-50
Yoon KC et al
2010/01/01
Species: Human, Applications: IHC-P PubMed
12 Curbishley SM et al. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am. J. Pathol. 2005 Sep;167(3):887-99
Curbishley SM et al
2005/01/01
Species: Human, Applications: Western Blot PubMed
13 Kohrgruber N et al. Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J. Immunol. 2004 Dec;173(11):6592-602
Kohrgruber N et al
2004/01/01
Species: Human, Applications: IHC PubMed
14 Bronger H et al. CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer. Br. J. Cancer 2016 Aug;115(5):553-63
Bronger H et al
2016/01/01
Species: Human, Applications: ICC PubMed
  • No.: 1
  • 文献情報:
    Suyama T et al. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Cancer 2005 Jan;103(2):
    Suyama T et al
    2005/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Pinto S et al. Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation. BMC Cancer 2014;14:118
    Pinto S et al
    2014/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Oo YH et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J. Immunol. 2010 Mar;184(6):2886-98
    Oo YH et al
    2010/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Franciszkiewicz K et al. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention. Cancer Res. 2009 Aug;69(15):6249-55
    Franciszkiewicz K et al
    2009/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Winter D et al. Down-modulation of CXCR3 surface expression and function in CD8+ T cells from cutaneous T cell lymphoma patients. J. Immunol. 2007 Sep;179(6):4272-82
    Winter D et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Immunodepletion
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Biancotto A et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007 May;109(10):4272-9
    Biancotto A et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Luminex Development
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Busuttil A et al. CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis. Eur. Respir. J. 2009 Sep;34(3):676-86
    Busuttil A et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Grivel JC et al. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 2007 Jun;21(10):1263-72
    Grivel JC et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Luminex Development
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Zahn S et al. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus. J. Invest. Dermatol. 2011 Jan;131(1):133-40
    Zahn S et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Biancotto A et al. Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo. AIDS Res. Hum. Retroviruses 2008 Mar;24(3):453-62
    Biancotto A et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Luminex Development
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Yoon KC et al. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest. Ophthalmol. Vis. Sci. 2010 Feb;51(2):643-50
    Yoon KC et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Curbishley SM et al. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am. J. Pathol. 2005 Sep;167(3):887-99
    Curbishley SM et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Kohrgruber N et al. Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J. Immunol. 2004 Dec;173(11):6592-602
    Kohrgruber N et al
    2004/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Bronger H et al. CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer. Br. J. Cancer 2016 Aug;115(5):553-63
    Bronger H et al
    2016/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed